Together with Erasmus University, we provide unique executive programs and counseling for Health-Tech and Med-Tech start-ups.

We are a science- and quality-focused company with the goal of providing innovative Point of Care and In Vitro Diagnostics technology to medical and health care professionals.

The POC testing market is set to reach $49 billion by 2020 and is growing in all major segments: hospitals, ambulatory care settings, physician offices and home care.
Our Clinical study division is a platform for various (university) clinical chemistry laboratories in the Netherlands, Germany and Belgium.
Together with Erasmus University, we provide unique executive programs and counseling for Health-Tech and Med-Tech start-ups.
We are a science- and quality-focused company with the goal of providing innovative Point of Care and In Vitro Diagnostics technology to medical and health care professionals.
The POC testing market is set to reach $49 billion by 2020 and is growing in all major segments: hospitals, ambulatory care settings, physician offices and home care.
Our Clinical study division is a platform for various (university) clinical chemistry laboratories in the Netherlands, Germany and Belgium.

This division is a platform for various (university) clinical chemistry laboratories in the Netherlands, Germany and Belgium. Together with these partners we support medical technology companies, pharmaceutical companies, the food industry and research institutes in performing clinical (intervention) studies.
These clinical studies fall under the Medical Research Involving Human Subjects Act. Thanks to the collaboration with academic clinical chemistry laboratories, we can offer measuring absorption of active ingredients, as well as effect monitoring on circulating biomarkers and clinical endpoints. Our skilled personnel will execute complete trials or assist you for only those parts where extra support is needed.

We provide professional, customized support regardless of your company’s current phase of business.

Clinical (Intervention) Studies:

Clinical (intervention) studies are controlled research studies testing the health benefit(s) of a new or improved product in human volunteers. Each study starts with its own research questions, which are explained in a study protocol. This protocol describes in detail how the study will be performed and why it is necessary to do it that way. The protocol also describes how the study group is defined, for example based on age, gender, or health status.

Project Management:

  • Feasibility analysis
  • a study protocol
  • contracts (also legal aspects)
  • grant proposals
  • Budget management
  • Medical Ethics Committee (MEC) approval
  • In-house execution of projects and supervision

    Routine laboratory (according to GLP guidelines):

    • Commercial biomarkers are tested in a routine laboratory, in compliance with GLP quality standards to ensure the quality and integrity of the generated data.

      Data Management:

      • Perform data-entry according to GCP/GLP guidelines
      • Perform advanced statistics using the latest version of SPSS software package
      • Write interim and final study reports
      • Give poster or oral presentations for clients or on scientific meetings

        Office Europe:
        Life Science Business
        Flight Forum 40
        5657 DB Eindhoven
        The Netherlands

        Contact information:
        E: info@lifesciencebusiness.nl

        Tel.: 0031-(0)40 - 7983021

        Office The Middle East :
        Life Science Business
        P. O. Box: 122022
        Sharjah
        The UAE